Discovering Undiscovered Gems in Asia June 2025
As global markets navigate a complex landscape of cooling labor markets and geopolitical tensions, the Asian market presents intriguing opportunities for investors seeking growth potential. In particular, small-cap stocks in Asia are capturing attention due to their resilience and adaptability amid fluctuating economic indicators, making them appealing candidates for those looking to uncover hidden gems in an evolving market environment.
Name
Debt To Equity
Revenue Growth
Earnings Growth
Health Rating
Wuxi Xinan Technology
NA
11.99%
4.45%
★★★★★★
Hangzhou Xili Intelligent TechnologyLtd
NA
11.73%
9.57%
★★★★★★
Hubei Three Gorges Tourism Group
11.24%
-15.32%
17.90%
★★★★★★
Shangri-La Hotel
NA
23.33%
39.56%
★★★★★★
Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou
15.92%
-28.99%
46.16%
★★★★★★
Tohoku Steel
NA
5.34%
-2.26%
★★★★★★
Lee's Pharmaceutical Holdings
13.81%
-0.34%
-27.47%
★★★★★☆
KC
2.19%
8.76%
-0.47%
★★★★★☆
ASRock Rack Incorporation
26.93%
225.32%
6287.64%
★★★★☆☆
Tibet TourismLtd
27.63%
9.10%
17.00%
★★★★☆☆
Click here to see the full list of 2608 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener.
Let's explore several standout options from the results in the screener.
Simply Wall St Value Rating: ★★★★★☆
Overview: ChengDu ShengNuo Biotec Co., Ltd. focuses on the research, development, production, sale, and export of peptide drugs and has a market capitalization of CN¥5.46 billion.
Operations: ShengNuo Biotec generates revenue primarily through the sale and export of peptide drugs. The company's financial performance is highlighted by its net profit margin, which has shown significant variation over recent periods.
ChengDu ShengNuo Biotec Ltd, a small player in the biotech sector, has shown impressive financial growth recently. Its Q1 2025 earnings reported sales of CNY 184.34 million, a significant jump from CNY 104.06 million the previous year. Net income also rose to CNY 47.12 million from CNY 16.47 million, showcasing strong profitability with basic earnings per share increasing to CNY 0.42 from CNY 0.15 last year. Despite its volatile share price over the past three months, the company's debt is well managed with an EBIT interest coverage of 14 times and a satisfactory net debt to equity ratio of approximately 28%.
Click here to discover the nuances of ChengDu ShengNuo BiotecLtd with our detailed analytical health report.
Assess ChengDu ShengNuo BiotecLtd's past performance with our detailed historical performance reports.
Simply Wall St Value Rating: ★★★★★★
Overview: Innuovo Technology Co., Ltd. operates in the research, development, production, and sale of rare earth permanent magnet materials both in China and internationally, with a market capitalization of CN¥12.20 billion.
Operations: The company's revenue primarily stems from the sale of rare earth permanent magnet materials. The net profit margin has shown variability, reflecting changes in cost structures and market conditions.
Innuovo Technology, a smaller player in Asia's tech scene, has been making waves with its impressive financial performance. Over the past year, earnings surged by 114%, outpacing the industry average of -4.4%. The company trades at 49% below its estimated fair value, indicating potential undervaluation. Despite a slight dip in sales to CNY 839 million from CNY 895 million last year, net income rose to CNY 69 million from CNY 66 million. Innuovo also announced a final cash dividend of CNY 1.24 per share for A shares in 2024 and completed a significant buyback of nearly 19 million shares worth over CNY106 million.
Click to explore a detailed breakdown of our findings in Innuovo Technology's health report.
Understand Innuovo Technology's track record by examining our Past report.
Simply Wall St Value Rating: ★★★★★★
Overview: Guomai Technologies, Inc. operates in China offering internet of things technology services, consulting and design, science park operation and development, as well as education services with a market cap of CN¥11.88 billion.
Operations: Guomai Technologies generates revenue primarily through its internet of things technology services, consulting and design, science park operation and development, and education services. The company focuses on providing comprehensive solutions in these areas to drive its financial performance. Net profit margin trends provide insight into the company's profitability dynamics over time.
Guomai Technologies, a debt-free player in the IT sector, stands out with a Price-To-Earnings ratio of 59x, notably lower than the industry average of 85.4x. The company recently reported impressive earnings growth of 67.4% over the past year, significantly outperforming the IT industry's -13.7%. Despite some volatility in its share price recently, Guomai's financial health remains robust with a notable one-off gain of CN¥81.8M impacting its latest results as of March 2025. Additionally, their dividend strategy includes a cash distribution plan offering CN¥0.80 per 10 shares for 2024 profits, indicating solid shareholder returns.
Delve into the full analysis health report here for a deeper understanding of Guomai Technologies.
Examine Guomai Technologies' past performance report to understand how it has performed in the past.
Investigate our full lineup of 2608 Asian Undiscovered Gems With Strong Fundamentals right here.
Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SHSE:688117 SZSE:000795 and SZSE:002093.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Q & M Dental Group (Singapore) Limited's (SGX:QC7) Intrinsic Value Is Potentially 89% Above Its Share Price
The projected fair value for Q & M Dental Group (Singapore) is S$0.72 based on 2 Stage Free Cash Flow to Equity Current share price of S$0.38 suggests Q & M Dental Group (Singapore) is potentially 47% undervalued Analyst price target for QC7 is S$0.37 which is 48% below our fair value estimate In this article we are going to estimate the intrinsic value of Q & M Dental Group (Singapore) Limited (SGX:QC7) by estimating the company's future cash flows and discounting them to their present value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex. We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (SGD, Millions) S$21.2m S$24.7m S$27.6m S$27.2m S$27.0m S$27.2m S$27.4m S$27.8m S$28.3m S$28.8m Growth Rate Estimate Source Analyst x1 Analyst x1 Analyst x1 Est @ -1.57% Est @ -0.39% Est @ 0.43% Est @ 1.01% Est @ 1.42% Est @ 1.70% Est @ 1.90% Present Value (SGD, Millions) Discounted @ 5.8% S$20.1 S$22.0 S$23.3 S$21.7 S$20.4 S$19.3 S$18.5 S$17.7 S$17.0 S$16.4 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = S$196m After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.4%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 5.8%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = S$29m× (1 + 2.4%) ÷ (5.8%– 2.4%) = S$852m Present Value of Terminal Value (PVTV)= TV / (1 + r)10= S$852m÷ ( 1 + 5.8%)10= S$484m The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is S$680m. The last step is to then divide the equity value by the number of shares outstanding. Relative to the current share price of S$0.4, the company appears quite good value at a 47% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Q & M Dental Group (Singapore) as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.8%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. See our latest analysis for Q & M Dental Group (Singapore) Strength Earnings growth over the past year exceeded the industry. Debt is not viewed as a risk. Dividends are covered by earnings and cash flows. Weakness Dividend is low compared to the top 25% of dividend payers in the Healthcare market. Opportunity Annual earnings are forecast to grow faster than the Singaporean market. Trading below our estimate of fair value by more than 20%. Significant insider buying over the past 3 months. Threat Revenue is forecast to grow slower than 20% per year. Although the valuation of a company is important, it ideally won't be the sole piece of analysis you scrutinize for a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. Why is the intrinsic value higher than the current share price? For Q & M Dental Group (Singapore), we've compiled three fundamental factors you should further examine: Risks: To that end, you should be aware of the 2 warning signs we've spotted with Q & M Dental Group (Singapore) . Future Earnings: How does QC7's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the SGX every day. If you want to find the calculation for other stocks just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30 minutes ago
- Yahoo
Mr Price Group Full Year 2025 Earnings: EPS: R14.16 (vs R12.76 in FY 2024)
Revenue: R40.7b (up 8.3% from FY 2024). Net income: R3.65b (up 11% from FY 2024). Profit margin: 9.0% (up from 8.7% in FY 2024). The increase in margin was driven by higher revenue. EPS: R14.16 (up from R12.76 in FY 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period The primary driver behind last 12 months revenue was the Apparel segment contributing a total revenue of R31.5b (77% of total revenue). Notably, cost of sales worth R23.6b amounted to 58% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to R8.46b (63% of total expenses). Explore how MRP's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Specialty Retail industry in South Africa. Performance of the South African Specialty Retail industry. The company's shares are down 3.5% from a week ago. We don't want to rain on the parade too much, but we did also find 1 warning sign for Mr Price Group that you need to be mindful of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30 minutes ago
- Yahoo
Asian Market Insights: Guangshen Railway And 2 Other Penny Stocks To Watch
As the Asian markets navigate a complex landscape of global trade tensions and economic shifts, investors are increasingly turning their attention to smaller companies that may offer unique opportunities. Penny stocks, though an older term, still represent a segment of the market where emerging or less-established firms can provide potential value. By focusing on those with strong financials and growth prospects, these stocks can present intriguing possibilities for investors looking to explore under-the-radar opportunities in Asia. Name Share Price Market Cap Financial Health Rating YKGI (Catalist:YK9) SGD0.10 SGD42.5M ★★★★★★ Lever Style (SEHK:1346) HK$1.15 HK$725.59M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.10 HK$1.75B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.425 SGD172.25M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.18 HK$1.97B ★★★★★★ Halcyon Technology (SET:HTECH) THB2.64 THB792M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.28 SGD8.97B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.179 SGD35.66M ★★★★★★ BRC Asia (SGX:BEC) SGD3.12 SGD855.97M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.52 HK$51.78B ★★★★★★ Click here to see the full list of 1,147 stocks from our Asian Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Guangshen Railway Company Limited operates in the railway passenger and freight transportation sectors in the People's Republic of China, with a market cap of HK$20.93 billion. Operations: The company generates revenue of CN¥27.39 billion from its operations in China. Market Cap: HK$20.93B Guangshen Railway's recent performance highlights a stable revenue stream, with Q1 2025 sales reaching CN¥6.90 billion, up from the previous year. Despite this growth, net income declined to CN¥468.18 million from CN¥546.94 million, reflecting a dip in profit margins from 4.5% to 3.6%. The company maintains strong financial health with more cash than total debt and robust interest coverage at 31.7x EBIT. However, earnings growth has been negative over the past year at -18.2%, underperforming the industry average of 2.7%. The stock trades significantly below its estimated fair value but has an unstable dividend history. Click here and access our complete financial health analysis report to understand the dynamics of Guangshen Railway. Examine Guangshen Railway's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Ming Yuan Cloud Group Holdings Limited is an investment holding company that offers cloud services and on-premises software in China, with a market cap of approximately HK$5.16 billion. Operations: The company's revenue is primarily derived from Cloud Services, which generated CN¥1.20 billion, and On-premise Software and Services, contributing CN¥239.73 million. Market Cap: HK$5.16B Ming Yuan Cloud Group Holdings, despite being unprofitable with a net loss of CN¥189.55 million for 2024, shows financial resilience through its substantial short-term assets of CN¥4.1 billion, which cover both short and long-term liabilities comfortably. The company is debt-free and has maintained a sufficient cash runway for over three years based on current free cash flow. While the stock trades below its estimated fair value, it has an unstable dividend track record but recently announced a special dividend of HK$0.1 per share to shareholders, showcasing shareholder returns amidst ongoing challenges in profitability growth. Jump into the full analysis health report here for a deeper understanding of Ming Yuan Cloud Group Holdings. Evaluate Ming Yuan Cloud Group Holdings' prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Jiumaojiu International Holdings Limited operates and manages Chinese cuisine restaurant brands across several countries including China, Singapore, Canada, Malaysia, Thailand, the United States, and Indonesia with a market cap of HK$3.54 billion. Operations: The company's revenue is primarily derived from its Tai Er segment, contributing CN¥4.41 billion, followed by Jiu Mao Jiu with CN¥546.18 million and Song Hot Pot with CN¥894.97 million. Market Cap: HK$3.54B Jiumaojiu International Holdings, with a market cap of HK$3.54 billion, has shown financial stability by maintaining more cash than its total debt and having short-term assets of CN¥2.3 billion that exceed both short and long-term liabilities. Despite a significant one-off loss impacting earnings, the company reported revenues primarily from its Tai Er segment at CN¥4.41 billion for 2024. Recent corporate actions include declaring a special dividend of HKD 0.02 per share despite reduced net profit margins to 0.9% from the previous year's 7.6%, reflecting ongoing profitability challenges amidst strategic shareholder returns initiatives. Dive into the specifics of Jiumaojiu International Holdings here with our thorough balance sheet health report. Assess Jiumaojiu International Holdings' future earnings estimates with our detailed growth reports. Discover the full array of 1,147 Asian Penny Stocks right here. Ready To Venture Into Other Investment Styles? Uncover 18 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:525 SEHK:909 and SEHK:9922. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
